Skip To Main Content
Huanying Ke on Muck Rack

Huanying Ke

As seen in: Cell Reports Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Huanying

Contact Huanying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effect of henagliflozin on aging biomarkers in patients with type 2 diabetes: A multicenter, randomized, double-blind, placebo-controlled study

|
By Jie Zhang, Wei Cai, Danfeng Liu, Youping Wang, Yuqing Huang, Yan Zhou, Meiling Yu, Shuping Xiong, Guigen Luo, Jianping Guo, Lingyan Julia Zhu, Yan Zhang, Yu Liu, Guanjun Huang, Chenxi Li, Jixiong Xu, Nianfeng Zheng, Fenglin Qiu, Huoping Zheng, Huaxia Gan, Huanying Ke, Chengbi Yu, Liangming Hu
| Cell Reports Medicine Verified
Keywords aging sodium-glucose cotransporter-2 inhibitors henagliflozin type 2 diabetes mellitus clinical trial metabolomics Introduction The global prevalence of type 2 diabetes mellitus (T2DM) is rising at an alarming rate. According to the International Diabetes Federation, approximately 700 million people worldwide will be affected by T2DM by 2045,1 posing a major threat to global public health. While diabetes is a metabolic disease, its pathogenesis is closely linked to the aging process.
Open in Who Shared Issue with article?
See all 1 articles